Explore
← New search
3 matching publication(s)
Extensive androgen receptor enhancer heterogeneity in primary prostate cancers underlies transcriptional diversity and metastatic potential.
PMID 36450752 · Nat Commun · 2022
L1
70/100
Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.⚑
PMID 32542016 · PLoS One · 2020
L1
51/100
⚑
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer.
PMID 32323921 · Mol Syst Biol · 2020
L1
66/100